Clinical Trials Sponsored by NGMedical GmbH

Total 56690 results

zr Pharma & GmbH

Completed

A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat (RECOMM)

Multiple Myeloma

United States
zr Pharma & GmbH

Completed

A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

Advanced Solid Tumor

Japan
zr Pharma & GmbH

Completed

Pharmacokinetic Drug-Drug Interaction Study of Rucaparib (DDI)

Neoplasms

Poland
zr Pharma & GmbH

Completed

A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens

Advanced Solid Tumors

United Kingdom
zr Pharma & GmbH

Completed

Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

Neoplasms

Poland, Slovakia, Hungary
Berlin Heart GmbH

Completed

The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients With Ventricular Assist Device Support (E-Motion)

Heart Diseases | Cardiovascular Diseases | Heart Failure | Cardiomyopathies | Ventricular Dysfunction

Germany
Croma-Pharma GmbH

Active, not recruiting

Saypha® VOLUME Lidocaine for Midface Augmentation (VOLIDO)

Moderate to Severe Midface Volume Deficit

United States
Stryker Trauma GmbH

Terminated

INFINITY™Total Ankle Replacement Follow-up (ITAR)

Arthritis, Rheumatoid

United States
Valneva Austria GmbH

Completed

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222 (COV-COMPARE)

SARS-CoV-2 Virus Infection

United Kingdom
Valneva Austria GmbH

Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)

Chikungunya Virus Infection

United States
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) (BioML)

Skeletal Abnormalities | Psychomotor Retardation

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Niemann Pick Type C Disease (BioNPC) (BioNPC)

Niemann-Pick Disease, Type C | Niemann-Pick Disease

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) (BioGM1/BioGM2)

Seizures | Mental Retardation | Hepato-splenomegaly | Dysostosis Multiplex

Egypt, Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin) (BioTyrosin)

Metabolic Disorders | Tyrosinosis | Hepatorenal Tyrosinemia | Fumarylacetoacetase Deficiency | Fah Deficiency

Germany, Sri Lanka, India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gaucher Disease: BioGaucher (BioGaucher) (BioGaucher)

Splenomegaly | Hepatomegaly

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Patients With Fabry Disease (BioFabry) (BioFabry)

Chronic Kidney Disease | Hearing Loss | Angiokeratomas | Ocular Abnormalities

Sri Lanka, India, Germany
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Glycogen Storage Diseases (BioGlycogen) (BioGlycogen)

Fructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditions

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Terminated

Biomarker for Cystic Fibrosis (BioCyFi)

Pancreatitis | Failure to Thrive | Meconium Ileus | Breathlessness | Lung Infection | Chronic Nasal Congestion | Clubbing Toes

India, Sri Lanka, Albania, Georgia, Pakistan
CENTOGENE GmbH Rostock

Terminated

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (TuScCom)

Lymphangioleiomyomatosis | Subependymal Giant Cell Astrocytoma | Facial Angiofibroma | Cortical Dysplasia | Renal Angiomyolipoma | Hypomelanotic Macules | Shagreen Patches | Ungual Fibromas | Cardiac Rhabdomyoma

Sri Lanka, Albania, Romania, Egypt, Pakistan, Georgia, India, Lithuania
MVZ Leopoldina GmbH

Completed

Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition (KETOCOMP)

Neoplasms

Germany
Atriva Therapeutics GmbH

Terminated

Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 (RESPIRE)

COVID-19

Germany, India, Netherlands, Poland, Romania, South Africa, Spain
Heidelberg Engineering GmbH

Completed

The Heidelberg Engineering ANTERION Imaging Agreement Study

Eye Abnormalities | Normal Eyes

United States
Croma-Pharma GmbH

Completed

SAVINO (Saypha® Volume LIdocaine in Nasolabial FOlds)

Moderate to Severe Nasolabial Folds

Austria
CENTOGENE GmbH Rostock

Terminated

European Alpha-Mannosidosis Participant (EUMAP)

Deafness | Immunodeficiency | Mental Retardation | Gingival Hypertrophy | Skeletal Abnormalities | Facial Dysmorphism

Germany, Switzerland
CENTOGENE GmbH Rostock

Completed

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP) (TRAP2-1)

Neuropathic Pain | Orthostatic Hypotension | Cardiac Failure | Gastrointestinal Disorders | Polyneuropathy, Amyloid

Spain, Austria, Hungary, North Macedonia, Poland, Serbia
Miltenyi Biomedicine GmbH

Completed

A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers

COVID-19

Germany
reMYND
NeuroScios GmbH

Completed

A Phase 1 (First in Human) Randomized, Double-blind, Placebo-controlled SAD, MAD Study With Oral REM0046127

Alzheimer Disease

Austria
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II (BLESS-II)

Glabellar Frown Lines
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I (BLESS I)

Glabellar Frown Lines
Croma-Pharma GmbH

Completed

Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation (SayLip)

Abnormal Lip

Austria
CENTOGENE GmbH Rostock

Completed

Epidemiological Analysis for Hereditary Angioedema Disease (EHA)

Abdominal Pain | Functional Abdominal Pain

United Kingdom, Germany, Turkey, Poland, Italy, Japan
Pari Pharma GmbH

Completed

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis

Rhinosinusitis

Germany
Enzyvant Therapeutics GmBH

Terminated

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

Stem Cell Transplantation

United States
CENTOGENE GmbH Rostock

Completed

Biomarkers for Inborn Errors of Metabolism (BioMetabol)

Inborn Errors of Metabolism | Biomarker

Egypt, Sri Lanka, Albania, Romania, Georgia, India, Lithuania, Pakistan
CENTOGENE GmbH Rostock

Completed

Biomarker for Duchenne Muscular Dystrophy (BioDuchenne)

Scoliosis | Muscular Atrophy | Duchenne Muscular Dystrophy | Lordosis | Muscular Weakness | Increased Lordosis/Scoliosis | Hyporeflexia | Red-Green Color Blindness

Egypt, India, Albania, Pakistan, Georgia, Lebanon, Romania, Sri Lanka
CENTOGENE GmbH Rostock

Completed

Biomarker for Hereditary AngioEdema Disease (BioHAE)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type III

Turkey, Armenia, Georgia, India, Peru, Poland, Romania
F2G Biotech GmbH

Completed

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

Hepatic Impairment

United States
CytoSorbents Europe GmbH

Terminated

Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery (CyTation)

Acute Coronary Syndrome

Germany, Luxembourg
Themis Bioscience GmbH

Completed

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (MV-ZIKA-RSP)

Zika Virus Infection

Austria
Myovant Sciences GmbH

Completed

A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

Healthy

United States
Merz Pharmaceuticals GmbH

Completed

Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability (SIPEXI)

Stroke | Cerebral Palsy | Intellectual Disability | Traumatic Brain Injury | Chronic Troublesome Sialorrhea

Georgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
Merz Pharmaceuticals GmbH

Completed

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy

Lower Limb Spasticity Due to Cerebral Palsy

Poland, Austria, Czechia, Estonia, France, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine
Urovant Sciences GmbH

Completed

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Croma-Pharma GmbH

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII) (BLESSIII)

Glabellar Frown Lines

United States
CENTOGENE GmbH Rostock

Completed

Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation (PadGau)

Parkinson Disease | Idiopathic Parkinson Disease

Thailand, Germany
CENTOGENE GmbH Rostock

Withdrawn

Fabry and Cardiomyopathy (FaCard) (FaCard)

Stroke, Acute | Cerebrovascular Accident | Cerebral Stroke

Germany
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines

Glabellar Lines

United States, Germany, Canada
Urovant Sciences GmbH

Completed

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (Empowur)

Overactive Bladder

United States
Heidelberg Engineering GmbH

Completed

The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study

Retinal Layer Separation

United States
Klinikum Bayreuth GmbH

Unknown

Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects

SARS-CoV-2 Infection

Germany

Clinical Trials Sponsored by NGMedical GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations